Alkermes overview

Alkermes plc is a biopharmaceutical company that focuses on central nervous system diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall.
The staff at Alkermes come from unusually diverse demographic backgrounds. The company is 32.9% female and 33.3% ethnic minorities. The diversity in Alkermes employees extends to employee political beliefs. Its employees are politically diverse and represent a balanced blend of political orientations, with 50.0% Democrats and 46.7% Republicans. Despite its impressive demographic and political diversity, Alkermes has employees who stay with the company for relatively short tenures. Alkermes staff members usually stay for 2.6 years. The average employee at Alkermes makes $77,636 per year. Pay at Alkermes is significantly lower than some of its highest paying competitors, like Amgen, Biogen, and Vertex Pharmaceuticals, which pay $92,091, $91,058, and $89,197, respectively.
A large technology company with 1,200 employees and an annual revenue of $1.0B, Alkermes is headquartered in the United States.

The Organization’s Mission

Our mission is make a difference, for each other and for the thousands of patients we serve with our medicines.

Industry

Biotechnology

Revenue

$1.0B

Employees

1,200

Founded in

-

Headquarters

-

Website

alkermes.com

Organization Type

Public

Is This Your Company?

The team at Alkermes

Key People
  • Richard Pops (ceo)

The Culture At Alkermes

Information provided by the company
Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Show More
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.

Alkermes Salaries

How much does Alkermes pay?
The national average salary for an Alkermes employee in the United States is $77,636 per year. Employees in the top 10 percent can make over $122,000 per year, while employees at the bottom 10 percent earn less than $49,000 per year.
9.5
Salary Score
Average Employee Earnings

Alkermes Salaries By Job Title

While Alkermes employees earn an average yearly salary of $77,636, different roles can command different wages. The higher paying positions at Alkermes include Senior Systems Analyst, Oracle Database Administrator, Information Technology Project Lead, and Team Leader. A typical Senior Systems Analyst salary at Alkermes is $117,484. Other roles at Alkermes include Office Assistant and Filler Operator. A Office Assistant at Alkermes earns an average yearly salary of $32,368.

Alkermes careers

On average, employees at Alkermes stay with the company for 2.6 years. Employees most commonly join Alkermes after leaving Genzyme. When they leave Alkermes, they most frequently get their next job at Genzyme.

Average Length of Employment
Amgen3.9 years
Biogen3.2 years

Alkermes

2.6 years
Top Employers Before Alkermes
Genzyme11.3 %
P&G6.7 %
Abbott6.0 %
Show More
Top Employers After Alkermes
Genzyme16.0 %
Pfizer11.1 %
Patheon6.8 %
Show More
00

Do you Work At Alkermes?

Help us make this company more transparent.

0

Alkermes Financial Performance

8.7
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$100M - $1B

Founded in

-

Organization type

Public

How Would You Rate The Company Culture Of Alkermes?

Have you worked at Alkermes? Help other job seekers by rating Alkermes.

Alkermes Competitors

Some of the competitors of Alkermes are Amgen, Biogen, and Vertex Pharmaceuticals. The wages at Amgen average higher than the other similar companies, where the median salary is $92,091 per year. Employees at Biogen earn an average of $91,058 per year, and the employees at Vertex Pharmaceuticals earn an average salary of $89,197 per year.

Frequently Asked Questions about Alkermes

How many Employees does Alkermes have?

Alkermes has 1,200 employees.

How much money does Alkermes make?

Alkermes generates $1.0B in revenue.

What industry is Alkermes in?

Alkermes is in the biotechnology industry.

What is Alkermes's mission?

Alkermes's mission statement is "Our mission is make a difference, for each other and for the thousands of patients we serve with our medicines."

What type of company is Alkermes?

Alkermes is a public company.

Who are Alkermes's competitors?

Alkermes competitors include Vertex Pharmaceuticals, Biogen, Amgen, Human Genome Sciences, Antares Pharma, BioMarin Pharmaceutical, Regeneron Pharmaceuticals, MedImmune, Genzyme, MannKind, Nektar Therapeutics, Novavax, Meso Scale Diagnostics, Fresenius Kabi, Alexion Pharmaceuticals, Osiris Therapeutics, Centocor, Seattle Genetics, Theravance, Cordis.

Who works at Alkermes?

Richard Pops (ceo)

What is Alkermes's website?

You can find the Alkermes website at alkermes.com.

Are you an executive, HR leader, or brand manager at Alkermes?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Alkermes, also known as ALKERMES CONTROLLED THERAPEUTICS INC, Alkermes, Alkermes Controlled Therapeutics, Inc., Alkermes Inc, Alkermes Inc. and Alkermes plc.

Zippia gives an in-depth look into the details of Alkermes, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alkermes. The employee data is based on information from people who have self-reported their past or current employments at Alkermes. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Alkermes and its employees or that of Zippia.